Serotonergic receptor subtypes and hallucinogen-induced stimulus control
- PMID: 10515304
- DOI: 10.1016/s0091-3057(99)00063-5
Serotonergic receptor subtypes and hallucinogen-induced stimulus control
Abstract
More than a quarter century has passed since the demonstration that indoleamine and phenethylamine hallucinogens can function as discriminative stimuli in the rat, and that serotonergic systems are critically involved. During that period our knowledge of the physiology, pharmacology, biochemistry, and molecular biology of serotonergic receptors has increased exponentially; with each advance it has been necessary to reexamine our assumptions regarding hallucinogen-induced stimulus control. Of particular interest is the hypothesis that a drug may act, at a molecular level, upon multiple receptors to produce, at a behavioral level, a compound discriminative stimulus. The salience of the individual elements of such compound stimuli may be influenced by a variety of experimental factors including training dose, pretreatment time, the state of sensitization of the systems being acted upon, and the nature of the drugs chosen for tests of generalization. This article provides examples of experimental approaches to these complexities using selective agonists and antagonists, depletion-induced sensitization, and antagonist correlation analysis.
Similar articles
-
Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.Psychopharmacology (Berl). 2004 Mar;172(2):233-40. doi: 10.1007/s00213-003-1636-2. Epub 2003 Nov 4. Psychopharmacology (Berl). 2004. PMID: 14598016
-
Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.Pharmacol Biochem Behav. 1998 Feb;59(2):419-25. doi: 10.1016/s0091-3057(97)00451-6. Pharmacol Biochem Behav. 1998. PMID: 9476990
-
Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.Psychopharmacology (Berl). 2009 Apr;203(2):251-63. doi: 10.1007/s00213-008-1356-8. Epub 2008 Nov 1. Psychopharmacology (Berl). 2009. PMID: 18979087
-
Hallucinogens in Drug Discrimination.Curr Top Behav Neurosci. 2018;36:201-219. doi: 10.1007/7854_2017_476. Curr Top Behav Neurosci. 2018. PMID: 28484970 Review.
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
Cited by
-
Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.Psychopharmacology (Berl). 2004 Mar;172(2):233-40. doi: 10.1007/s00213-003-1636-2. Epub 2003 Nov 4. Psychopharmacology (Berl). 2004. PMID: 14598016
-
Indolealkylamines: biotransformations and potential drug-drug interactions.AAPS J. 2008 Jun;10(2):242-53. doi: 10.1208/s12248-008-9028-5. Epub 2008 May 3. AAPS J. 2008. PMID: 18454322 Free PMC article. Review.
-
Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.J Pharmacol Exp Ther. 2010 Dec;335(3):728-34. doi: 10.1124/jpet.110.172247. Epub 2010 Sep 21. J Pharmacol Exp Ther. 2010. PMID: 20858706 Free PMC article.
-
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Drug Test Anal. 2012 Jul-Aug;4(7-8):556-76. doi: 10.1002/dta.1333. Epub 2012 Apr 19. Drug Test Anal. 2012. PMID: 22517680 Free PMC article. Review.
-
Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.Pharmacol Biochem Behav. 2005 Aug;81(4):750-7. doi: 10.1016/j.pbb.2005.05.011. Pharmacol Biochem Behav. 2005. PMID: 15972234 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources